期刊
PHYTOMEDICINE
卷 26, 期 -, 页码 62-68出版社
ELSEVIER GMBH
DOI: 10.1016/j.phymed.2017.01.010
关键词
Xuesaitong dispersible tablet; Aspirin; Pharmacokinetics; Herb-drug interaction; UHPLC-MS/MS
资金
- National Natural Science Foundation of China [81573685, 81403174]
- Administration of Traditional Chinese Medicine of Jiangsu Province [YB2015095]
Background: Xuesaitong dispersible tablet (XST) product has been clinically proven to be effective for treating cardio-cerebrovascular disease. Furthermore, herb-drug interactions between the XST product and drugs that are commonly co-administered, such as aspirin (ASA), must be explored to ensure safe clinical use. Study design and methods: The current study aims to investigate whether the XST product interacts with ASA when they are administered concomitantly to ensure safety and efficacy. A ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for the simultaneous determination of ginsenoside Rg1 (Rg1), ginsenoside Rd (Rd), notoginsenoside R1 (R1) and salicylic acid (SA) in rat plasma to investigate the pharmacokinetic interaction of XST and ASA in blood stasis model rats. Results and conclusion: The ASA and XST combination noticeably altered R1 and Rg1 absorption, distribution and disposition. This study indicates that co-administration of XST and ASA can cause an apparent herb-drug pharmacokinetic interaction in blood stasis model rats. (C) 2017 Elsevier GmbH. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据